Form 4: Emergent BioSolutions Director Zsolt Harsanyi Receives Stock Options and Restricted Stock Units

Director Zsolt Harsanyi reports receiving stock options and restricted stock units from Emergent BioSolutions as part of their compensation for board and committee service.

Summary

• On May 23, 2024, Zsolt Harsanyi, a director at Emergent BioSolutions Inc., received 17,430 restricted stock units (RSUs) and 25,748 stock options.
• The RSUs and stock options were granted under the company's Stock Incentive Plan as compensation for board and committee service.
• The RSUs represent the right to receive one share of Emergent BioSolutions common stock upon vesting.
• The stock options have an exercise price of $5.02 and represent the right to purchase one share of the company's common stock upon vesting.
• Both the RSUs and stock options will vest on the day prior to the one-year anniversary of the grant date, contingent upon Harsanyi remaining a member of the board of directors.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive as it reflects standard compensation practices for board members, aligning their interests with shareholders.

Positives

• The grant of RSUs and stock options aligns the director's interests with those of the shareholders.
• The vesting requirements incentivize continued service on the board of directors.

Future Outlook

The document does not contain specific forward-looking statements beyond the vesting schedule of the granted securities.

Industry Context

This type of equity compensation is standard practice for directors of publicly traded companies to align their interests with shareholders and incentivize long-term value creation.

Comparison to Industry Standards

• Equity compensation for board members is a common practice across the biotechnology industry.
• Companies like Moderna and Pfizer also grant stock options and RSUs to their directors as part of their compensation packages.
• The specific value and vesting schedules can vary based on company size, performance, and industry benchmarks.

Stakeholder Impact

• Shareholders may view the equity grants positively as they align the director's interests with the company's long-term performance.
• The vesting requirements incentivize the director to remain engaged and contribute to the company's success.

Key Dates